Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |